Antibody-guided alpha radiation effectively damages fungal biofilms

被引:24
作者
Martinez, L. R.
Bryan, R. A.
Apostolidis, C.
Morgenstern, A.
Casadevall, A.
Dadachova, E.
机构
[1] Albert Einstein Coll Med, Dept Nucl Med, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Commiss European Communities, Joint Res Ctr, Inst Transuranium Elements, D-7500 Karlsruhe, Germany
关键词
D O I
10.1128/AAC.00120-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The use of indwelling medical devices-pacemakers, prosthetic joints, catheters-is rapidly growing and is often complicated by infections with biofilm-forming microbes that are resistant to antimicrobial agents and host defense mechanisms. We investigated for the first time the use of microbe-specific monoclonal antibodies (MAbs) as delivery vehicles for targeting biofilms with cytocidal radiation. MAb 18B7 (immunoglobulin G1 [IgG1]), which binds to capsular polysaccharides of the human pathogenic fungus Cryptococcus neoformans penetrated cryptococcal biofilms, as shown by confocal microscopy. When the alpha radiation-emitter 213-Bismuth (Bi-213) was attached to MAb 18B7 and the radiolabelled MAb was added to C. neoformans biofilms, there was a 50% reduction in biofilm metabolic activity. In contrast, when the IgM MAb 13F1 labeled with Bi-213 was used there was no penetration of the fungal biofilm and no damage. Unlabeled 18B7, Bi-213-labeled nonspecific MAbs, and gamma and beta types of radiation did not have an effect on biofilms. The lack of efficacy of gamma and beta radiation probably reflects the radioprotective properties of polysaccharide biofilm matrix. Our results indicate that C. neoformans biofilms are susceptible to treatment with antibody-targeted alpha radiation, suggesting a novel option for the prevention or treatment of microbial biofilms on indwelling medical devices.
引用
收藏
页码:2132 / 2136
页数:5
相关论文
共 26 条
[1]   Penetration of Candida biofilms by antifungal agents [J].
Al-Fattani, MA ;
Douglas, LJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3291-3297
[2]   Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans [J].
Bryan, RA ;
Zaragoza, O ;
Zhang, T ;
Ortiz, G ;
Casadevall, A ;
Dadachova, E .
EUKARYOTIC CELL, 2005, 4 (02) :465-475
[3]   Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies [J].
Casadevall, A ;
Cleare, W ;
Feldmesser, M ;
Glatman-Freedman, A ;
Goldman, DL ;
Kozel, TR ;
Lendvai, N ;
Mukherjee, J ;
Pirofski, LA ;
Rivera, J ;
Rosas, AL ;
Scharff, MD ;
Valadon, P ;
Westin, K ;
Zhong, ZJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1437-1446
[4]   Passive antibody therapy for infectious diseases [J].
Casadevall, A ;
Dadachova, E ;
Pirofski, L .
NATURE REVIEWS MICROBIOLOGY, 2004, 2 (09) :695-703
[5]   Antifungal resistance of candidal biofilms formed on denture acrylic in vitro [J].
Chandra, J ;
Mukherjee, PK ;
Leidich, SD ;
Faddoul, FF ;
Hoyer, LL ;
Douglas, LJ ;
Ghannoum, MA .
JOURNAL OF DENTAL RESEARCH, 2001, 80 (03) :903-908
[6]   Feasibility of radioimmunotherapy of experimental pneumococcal infection [J].
Dadachova, E ;
Burns, T ;
Bryan, RA ;
Apostolidis, C ;
Brechbiel, MW ;
Nosanchuk, JD ;
Casadevall, A ;
Pirofski, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (05) :1624-1629
[7]   Evaluation of acute hematologic and long-term pulmonary toxicities of radioimmunotherapy of Cryptococcus neoformans infection in murine models [J].
Dadachova, E ;
Bryan, RA ;
Frenkel, A ;
Zhang, T ;
Apostolidis, C ;
Nosanchuk, JS ;
Nosanchuk, JD ;
Casadevall, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :1004-1006
[8]  
Dadachova E, 2004, J NUCL MED, V45, P313
[9]   Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection [J].
Dadachova, E ;
Nakouzi, A ;
Bryan, RA ;
Casadevall, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) :10942-10947
[10]  
Dadachova Ekaterina, 2005, Expert Opin Drug Deliv, V2, P1075, DOI 10.1517/17425247.2.6.1075